Lamothe Jeffrey G. 4
4 · Aptevo Therapeutics Inc. · Filed Aug 10, 2023
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2023-08-08+1,833→ 26,504 total - Exercise/Conversion
Restricted Stock Unit
2023-08-08−1,833→ 3,667 total→ Common Stock (1,833 underlying) - Exercise/Conversion
Common Stock
2023-08-08+11,979→ 24,671 total - Exercise/Conversion
Restricted Stock Unit
2023-08-08−11,979→ 11,979 total→ Common Stock (11,979 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
- [F3]On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.